A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

We conducted a genome-wide association study (GWAS) of breast cancer by genotyping 528,173 SNPs in 1,145 postmenopausal women of European ancestry with invasive breast cancer and 1,142 controls. We identified four SNPs in intron 2 of FGFR2 (which encodes a receptor tyrosine kinase and is amplified or overexpressed in some breast cancers) that were highly associated with breast cancer and confirmed this association in 1,776 affected individuals and 2,072 controls from three additional studies. Across the four studies, the association with all four SNPs was highly statistically significant (Ptrend for the most strongly associated SNP (rs1219648) = 1.1 × 10−10; population attributable risk = 16%). Four SNPs at other loci most strongly associated with breast cancer in the initial GWAS were not associated in the replication studies. Our summary results from the GWAS are available online in a form that should speed the identification of additional risk loci.

[1]  D P Byar,et al.  Estimating the population attributable risk for multiple risk factors using case-control data. , 1985, American journal of epidemiology.

[2]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.

[3]  G. Colditz,et al.  Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.

[4]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[5]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[6]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[7]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[8]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[9]  Peter Kraft,et al.  Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques , 2005, Genetic epidemiology.

[10]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[11]  C. Dickson,et al.  Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.

[12]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[13]  M. Thun,et al.  Association of Polymorphisms in the Paraoxonase 1 Gene with Breast Cancer Incidence in the CPS-II Nutrition Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.

[14]  R. Durbin,et al.  Mapping trait loci by use of inferred ancestral recombination graphs. , 2006, American journal of human genetics.

[15]  Barry Rosen,et al.  Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. , 2006, Journal of the National Cancer Institute.

[16]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[17]  I. Pe’er,et al.  Optimal two‐stage genotyping designs for genome‐wide association scans , 2006, Genetic epidemiology.

[18]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[19]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[20]  S. Ethier,et al.  Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells , 2007, Journal of cellular physiology.

[21]  S. Hankinson,et al.  A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Mantzoros,et al.  Circulating Insulin and C-Peptide Levels and Risk of Breast Cancer among Predominately Premenopausal Women , 2007, Cancer Epidemiology Biomarkers & Prevention.

[23]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[24]  R. Hayes,et al.  RNASEL Arg462Gln polymorphism and prostate cancer in PLCO , 2007, The Prostate.

[25]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.